R&D News – SYN-005 in Pertussis

Synthetic Biologics, a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases,¬†announced today positive preclinical research findings for SYN-005, the Company’s proprietary monoclonal antibody (mAb) combination therapy for treating Pertussis (whooping cough), in two non-human primate studies (n=15). In the second pertussis study in particular, SYN-005 was [...]

Hello world

Wellspring at long last (kicking, screaming and eye-rolling) parties on with a new look, feel and leveled optimism about the power of social media. So join the party, lurk around with me, and email anytime.